Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Winsome Cheung
Winsome Cheung
London +44 20 7067 2108 wcheung@cov.com Download V-card

Winsome Cheung is an associate in Covington’s life sciences transactional group. 

Ms. Cheung advises clients on a broad range of life science agreements, licensing agreements, intellectual property law and commercial matters.

  • Illumina on its strategic alliance agreement with Genomics England in respect of sequencing genomes of patients with cancer and rare diseases, as part of a four-year UK government project to decode 100,000 human genomes.
  • Abingworth on the establishment of and investment in GammaDelta Therapeutics Ltd, an immunotherapy company.
  • AstraZeneca on its acquisition of the core respiratory business of Takeda.
  • AstraZeneca on an agreement with ProStrakan Group, for the rights to Moventig in the European Union, Iceland, Norway, Switzerland and Liechtenstein.
  • Allergy Therapeutics in connection with a license agreement with respect of virus-like particle technology.
  • GammaDelta Therapeutics Limited on a strategic collaboration with Takeda to develop GammaDelta Therapeutics’ novel T cell platform, which is based on the unique properties of gamma delta (γδ) T cells derived from human tissues.